124 related articles for article (PubMed ID: 31933204)
1. In Vitro Generation of Stem Cell Memory-Like T Cells from Activated T Cells.
Ando M; Ikeda M; Yoshimura A; Kondo T
Methods Mol Biol; 2020; 2111():127-139. PubMed ID: 31933204
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Conversion of Activated T Cells into Stem Cell Memory-Like T Cells.
Kondo T; Imura Y; Ando M; Chikuma S; Yoshimura A
Methods Mol Biol; 2019; 2048():41-51. PubMed ID: 31396927
[TBL] [Abstract][Full Text] [Related]
3. The NOTCH-FOXM1 Axis Plays a Key Role in Mitochondrial Biogenesis in the Induction of Human Stem Cell Memory-like CAR-T Cells.
Kondo T; Ando M; Nagai N; Tomisato W; Srirat T; Liu B; Mise-Omata S; Ikeda M; Chikuma S; Nishimasu H; Nureki O; Ohmura M; Hayakawa N; Hishiki T; Uchibori R; Ozawa K; Yoshimura A
Cancer Res; 2020 Feb; 80(3):471-483. PubMed ID: 31767627
[TBL] [Abstract][Full Text] [Related]
4. Generation and application of human induced-stem cell memory T cells for adoptive immunotherapy.
Kondo T; Imura Y; Chikuma S; Hibino S; Omata-Mise S; Ando M; Akanuma T; Iizuka M; Sakai R; Morita R; Yoshimura A
Cancer Sci; 2018 Jul; 109(7):2130-2140. PubMed ID: 29790621
[TBL] [Abstract][Full Text] [Related]
5. Rejuvenating Effector/Exhausted CAR T Cells to Stem Cell Memory-Like CAR T Cells By Resting Them in the Presence of CXCL12 and the NOTCH Ligand.
Ando M; Kondo T; Tomisato W; Ito M; Shichino S; Srirat T; Mise-Omata S; Nakagawara K; Yoshimura A
Cancer Res Commun; 2021 Oct; 1(1):41-55. PubMed ID: 36860911
[TBL] [Abstract][Full Text] [Related]
6. Notch-mediated conversion of activated T cells into stem cell memory-like T cells for adoptive immunotherapy.
Kondo T; Morita R; Okuzono Y; Nakatsukasa H; Sekiya T; Chikuma S; Shichita T; Kanamori M; Kubo M; Koga K; Miyazaki T; Kassai Y; Yoshimura A
Nat Commun; 2017 May; 8():15338. PubMed ID: 28530241
[TBL] [Abstract][Full Text] [Related]
7. Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity.
Torres Chavez A; McKenna MK; Canestrari E; Dann CT; Ramos CA; Lulla P; Leen AM; Vera JF; Watanabe N
J Immunother Cancer; 2019 Nov; 7(1):330. PubMed ID: 31779709
[TBL] [Abstract][Full Text] [Related]
8. Stem cell-like memory T cells: The generation and application.
Wang Y; Qiu F; Xu Y; Hou X; Zhang Z; Huang L; Wang H; Xing H; Wu S
J Leukoc Biol; 2021 Dec; 110(6):1209-1223. PubMed ID: 34402104
[TBL] [Abstract][Full Text] [Related]
9. Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion.
Kaartinen T; Luostarinen A; Maliniemi P; Keto J; Arvas M; Belt H; Koponen J; Mäkinen PI; Loskog A; Mustjoki S; Porkka K; Ylä-Herttuala S; Korhonen M
Cytotherapy; 2017 Jun; 19(6):689-702. PubMed ID: 28411126
[TBL] [Abstract][Full Text] [Related]
10. Antigen-specific CD8+ memory stem T cells generated from human peripheral blood effectively eradicate allogeneic targets in mice.
Guan L; Li X; Wei J; Liang Z; Yang J; Weng X; Wu X
Stem Cell Res Ther; 2018 Dec; 9(1):337. PubMed ID: 30526661
[TBL] [Abstract][Full Text] [Related]
11.
Bonte S; de Munter S; Billiet L; Goetgeluk G; Ingels J; Jansen H; Pille M; de Cock L; Weening K; Taghon T; Leclercq G; Vandekerckhove B; Kerre T
Oncoimmunology; 2021; 10(1):1954800. PubMed ID: 34367734
[TBL] [Abstract][Full Text] [Related]
12. IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype.
Alizadeh D; Wong RA; Yang X; Wang D; Pecoraro JR; Kuo CF; Aguilar B; Qi Y; Ann DK; Starr R; Urak R; Wang X; Forman SJ; Brown CE
Cancer Immunol Res; 2019 May; 7(5):759-772. PubMed ID: 30890531
[TBL] [Abstract][Full Text] [Related]
13. Universal Ready-to-Use Immunotherapeutic Approach for the Treatment of Cancer: Expanded and Activated Polyclonal γδ Memory T Cells.
Polito VA; Cristantielli R; Weber G; Del Bufalo F; Belardinilli T; Arnone CM; Petretto A; Antonucci L; Giorda E; Tumino N; Pitisci A; De Angelis B; Quintarelli C; Locatelli F; Caruana I
Front Immunol; 2019; 10():2717. PubMed ID: 31824502
[TBL] [Abstract][Full Text] [Related]
14. Optimization of manufacturing conditions for chimeric antigen receptor T cells to favor cells with a central memory phenotype.
Gargett T; Truong N; Ebert LM; Yu W; Brown MP
Cytotherapy; 2019 Jun; 21(6):593-602. PubMed ID: 30975603
[TBL] [Abstract][Full Text] [Related]
15. Manipulation of human early T lymphopoiesis by coculture on human bone marrow stromal cells: potential utility for adoptive immunotherapy.
Liu B; Ohishi K; Orito Y; Nakamori Y; Nishikawa H; Ino K; Suzuki K; Matsumoto T; Masuya M; Hamada H; Mineno J; Ono R; Nosaka T; Shiku H; Katayama N
Exp Hematol; 2013 Apr; 41(4):367-76.e1. PubMed ID: 23257689
[TBL] [Abstract][Full Text] [Related]
16. Memory stem T cells modified with a redesigned CD30-chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma.
Alvarez-Fernández C; Escribà-Garcia L; Caballero AC; Escudero-López E; Ujaldón-Miró C; Montserrat-Torres R; Pujol-Fernández P; Sierra J; Briones J
Clin Transl Immunology; 2021; 10(4):e1268. PubMed ID: 33968404
[TBL] [Abstract][Full Text] [Related]
17. Long-term in vitro expansion ensures increased yield of central memory T cells as perspective for manufacturing challenges.
Herda S; Heimann A; Obermayer B; Ciraolo E; Althoff S; Ruß J; Grunert C; Busse A; Bullinger L; Pezzutto A; Blankenstein T; Beule D; Na IK
Int J Cancer; 2021 Jun; 148(12):3097-3110. PubMed ID: 33600609
[TBL] [Abstract][Full Text] [Related]
18. Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells.
Hurton LV; Singh H; Najjar AM; Switzer KC; Mi T; Maiti S; Olivares S; Rabinovich B; Huls H; Forget MA; Datar V; Kebriaei P; Lee DA; Champlin RE; Cooper LJ
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):E7788-E7797. PubMed ID: 27849617
[TBL] [Abstract][Full Text] [Related]
19. Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via Notch signaling.
Zhao Y; Parkhurst MR; Zheng Z; Cohen CJ; Riley JP; Gattinoni L; Restifo NP; Rosenberg SA; Morgan RA
Cancer Res; 2007 Mar; 67(6):2425-9. PubMed ID: 17363559
[TBL] [Abstract][Full Text] [Related]
20. Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.
Figueroa JA; Reidy A; Mirandola L; Trotter K; Suvorava N; Figueroa A; Konala V; Aulakh A; Littlefield L; Grizzi F; Rahman RL; Jenkins MR; Musgrove B; Radhi S; D'Cunha N; D'Cunha LN; Hermonat PL; Cobos E; Chiriva-Internati M
Int Rev Immunol; 2015 Mar; 34(2):154-87. PubMed ID: 25901860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
